Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Swainson

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Psychiatry|March 29, 2020
CorrectionJennifer Swainson, Atul Khullar
Journal of Clinical Psychopharmacology|June 19, 2018
Maintenance Ketamine Therapy for Treatment-Resistant DepressionShaina Archer, Carson Chrenek, Jennifer Swainson
Journal of Patient Experience|December 11, 2023
An Emergency Department Survey on Research Participation in the Patient With Suicidal Ideation or Suicide AttemptKevin Skoblenick, Marissa Hsu, Jennifer Swainson
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|June 26, 2010
Psychiatric residents as teachers: development and evaluation of a teaching manualJennifer Swainson, Melanie Marsh, Philip G Tibbo
Depression and Anxiety|March 7, 2003
Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophreniaPhilip Tibbo, Jennifer Swainson, Pierre Chue, et al.
PLOS Mental Health|February 9, 2026
Ketamine for mental health - A naturalistic inventory of prescribing practices, safety, and adverse effectsMaegan Stuart, Ian Stefanuk, Rebecca Comeau, et al.
JMIR Research Protocols|May 23, 2022
Efficacy and Tolerability of Two Novel "Standard of Care" Treatments-Intranasal Esketamine Versus Intravenous Ketamine-for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational StudyGilmar Gutierrez, Joshua Rosenblat, Emily Hawken, et al.
Frontiers in Psychiatry|October 17, 2022
Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension managementRyan Yip, Jennifer Swainson, Atul Khullar, et al.
Frontiers in Psychiatry|March 15, 2021
Impact of Pandemics/Epidemics on Emergency Department Utilization for Mental Health and Substance Use: A Rapid ReviewJulie Munich, Liz Dennett, Jennifer Swainson, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 28, 2025
Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment ModelsJennifer Swainson, Elisa Brietzke, Atul Khullar, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Psychiatry|March 29, 2020
CorrectionJennifer Swainson, Atul Khullar
Journal of Clinical Psychopharmacology|June 19, 2018
Maintenance Ketamine Therapy for Treatment-Resistant DepressionShaina Archer, Carson Chrenek, Jennifer Swainson
Journal of Patient Experience|December 11, 2023
An Emergency Department Survey on Research Participation in the Patient With Suicidal Ideation or Suicide AttemptKevin Skoblenick, Marissa Hsu, Jennifer Swainson
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|June 26, 2010
Psychiatric residents as teachers: development and evaluation of a teaching manualJennifer Swainson, Melanie Marsh, Philip G Tibbo
Depression and Anxiety|March 7, 2003
Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophreniaPhilip Tibbo, Jennifer Swainson, Pierre Chue, et al.
PLOS Mental Health|February 9, 2026
Ketamine for mental health - A naturalistic inventory of prescribing practices, safety, and adverse effectsMaegan Stuart, Ian Stefanuk, Rebecca Comeau, et al.
JMIR Research Protocols|May 23, 2022
Efficacy and Tolerability of Two Novel "Standard of Care" Treatments-Intranasal Esketamine Versus Intravenous Ketamine-for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational StudyGilmar Gutierrez, Joshua Rosenblat, Emily Hawken, et al.
Frontiers in Psychiatry|October 17, 2022
Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension managementRyan Yip, Jennifer Swainson, Atul Khullar, et al.
Frontiers in Psychiatry|March 15, 2021
Impact of Pandemics/Epidemics on Emergency Department Utilization for Mental Health and Substance Use: A Rapid ReviewJulie Munich, Liz Dennett, Jennifer Swainson, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 28, 2025
Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment ModelsJennifer Swainson, Elisa Brietzke, Atul Khullar, et al.
Pageof 4